RYVYL has taken significant steps to secure its position on the Nasdaq by implementing a reverse stock split and increasing its authorized shares. These measures were overwhelmingly supported by shareholders during the recent Annual Meeting, reflecting a strong commitment to maintaining shareholder value amidst upcoming changes, as stated in the official source.
RYVYL Shareholders Approve Reverse Stock Split
During the 2025 Annual Meeting of Shareholders, RYVYL's shareholders voted in favor of a reverse stock split and an increase in authorized shares, with over 90% approval. This decision was crucial for ensuring compliance with Nasdaq listing requirements, which are vital for the company's future and the anticipated merger.
Roundtable's Significant Investment
Roundtable, RYVYL's largest shareholder, played a pivotal role in this process by not only supporting the proposals but also increasing its investment to $65 million. The board of RYVYL will determine the exact ratio for the reverse stock split based on prevailing market conditions. This move is expected to bolster shareholder value and streamline the merger process.
While RYVYL has taken proactive steps to secure its Nasdaq listing, Kindly MD is currently facing a critical challenge with a notice from Nasdaq regarding its stock performance. For more details, see this article.
